Showing 921 - 940 results of 101,155 for search '(( 2 step decrease ) OR ( 5 ((((mg decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.54s Refine Results
  1. 921
  2. 922
  3. 923
  4. 924
  5. 925
  6. 926
  7. 927
  8. 928
  9. 929
  10. 930

    Netrin-1 overexpression increases HCV RNA and specific infectivity of HCV virions in vitro whereas Netrin-1 depletion decreases HCV RNA and specific infectivity in vitro. by Marie-Laure Plissonnier (337713)

    Published 2016
    “…Netrin-1 depletion impedes HCV. Huh7.5 cells were transfected with siRNAs, infected at a MOI of 0.1 24 h after seeding, and trypsinized at day five post-infection before a second siRNA transfection. …”
  11. 931
  12. 932
  13. 933
  14. 934

    Flowchart of data preprocessing steps. by Ehsan Yaghmaei (16985784)

    Published 2023
    “…Our results show that, compared to the absence of medication scenario, the Memantine monotherapy, and the Donepezil monotherapy, the combined use of Donepezil and Memantine treatment significantly reduces the average number of hospital or emergency department visits per year by 0.078 (13.8%), 0.144 (25.5%), and 0.132 days (23.4%), respectively. The assessed decline in the average number of hospital or emergency department visits per year is consequently associated with a substantial reduction in medical costs. …”
  15. 935
  16. 936

    Decreased <i>Pax2</i> expression in <i>p53<sup>−/−</sup></i> embryonic kidneys. by Zubaida Saifudeen (135684)

    Published 2012
    “…<b>B</b>) In situ hybridization. Decreased expression of <i>Pax2</i> mRNA at E12.5. …”
  17. 937

    Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma... by figshare admin karger (2628495)

    Published 2025
    “…At 18 months, a statistically significantly lower incidence of hepatic decompensation was seen in the overall allopurinol exposure cohort (OR: 0.77; 95% CI: 0.70-0.84), the 100 mg cohort (OR: 0.66; 95% CI: 0.57 to 0.76), and 300 mg cohort (OR: 0.76, 95% CI: 0.62 to 0.94). …”
  18. 938

    MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

    Published 2014
    “…Anti-phospho-cofilin antibody showed that MK-STYX decreased cofilin phosphorylation in non-stimulated cells relative to the MK-STYX shRNA-A. …”
  19. 939
  20. 940